Bengaluru FC confirm three COVID-19 cases ahead of AFC Qualifiers
The positive cases were reported during BFC's training camp which began in Panaji on 5 April.

Representational photo. Getty Images
Panaji: Indian football club Bengaluru FC on Wednesday said three COVID-19 cases have been detected among its players and staff after the side assembled for training here ahead of its AFC Qualifiers (Preliminary Stage Two) match on 14 April.
The positive cases were reported during BFC's training camp which began in Panaji on 5 April.
"Latest COVID-19 tests within the Blues' camp in Goa have shown three positive cases among players and staff," the club informed on its Twitter handle.
"Bengaluru FC continues to take all the necessary precautions at the highest levels to stay safe, secure and healthy."
UPDATE: Latest COVID-19
tests within the Blues’ camp in Goa have shown three positive cases among players and staff. Bengaluru FC continues to take all the necessary precautions at the highest levels to stay safe, secure and healthy.
— Bengaluru FC (@bengalurufc) April 7, 2021
BFC will take on either Nepal Army Club or Sri Lanka Police at the GMC Stadium in Bambolim on 14 April.
Earlier, BFC skipper and India star Sunil Chettri had tested positive for COVID-19 . The striker, however, has recovered.
BFC finished seventh on the table at the end of the last ISL league stage.
The former champions logged 22 points after winning five matches, drawing seven and losing eight games.
also read

Maharashtra sees highest single-day jump with 31,855 COVID-19 cases; over 5,000 test positive in Mumbai
Mumbai's two neighbouring cities Navi Mumbai and Kalyan-Dombivli reported 566 and 929 new cases respectively

WTO says recovery of global trade in 2021 hinges on widespread COVID-19 vaccination
While the rebound this year will be stronger than expected, WTO's growth forecast states it could slow to 4 percent in 2022.

Serum institute begins Covovax clinical trials in India, vaccine may launch by September
The development and commercialisation pact between Novavax and SII excludes major upper-middle and high-income countries as they retain the rights